Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2012

View Archived Issues

Phase III trial compares antibiotics in children with neglected tropical disease

Study links gene's methylation status to response of colorectal cancer to chemotherapy

Sustained T-cell responses obtained with HCV vaccine based on rare adenoviral vectors

Novel dual specificity protein kinase TTK inhibitors reported

XiberScience identifies new RhoA-inhibiting peptides

Novel PET imaging agent described for use in breast cancer diagnosis

Medivir designs new cathepsin S inhibitors

Stem Cell Educator therapy evaluated in patients with type 1 diabetes

Chinese company patents novel PPAR agonists

Pfizer presents new glucokinase activators

Otsuka Pharmaceutical and UCB adjust focus of collaboration

Otsuka Pharmaceutical files NDA in Japan

First study site chosen for pivotal phase II/III trial in hemophilia

Treatment begins in phase II study of Advaxis' ADXS-HPV

Spherix completes SPX-106 toxicology study for IND submission

Fifth Merrimack Pharmaceuticals program advances to clinic

World's first hepatitis E vaccine approved in China

Fostoin set for launch in Japan

Health Canada grants priority review status to Cinryze

Phytopharm reports preclinical data on Cogane in ALS

Astex Pharmaceuticals transfers results of epigenetics project to GSK

Nuron Biotech licenses flu vaccine to Mitsubishi Tanabe Pharma for Japan

Photocure completes enrollment in phase IIb trial of Visonac

Sobi signs licensing agreement for therapy for neonates with diuresis and seizures

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...